ActiTrexx GmbH Alternatives & Competitors
12 companies similar to ActiTrexx GmbH — ATreg - For a life without Transplant Rejection
Companies similar to ActiTrexx GmbH
-logo.jpg "Enlivex Therapeutics (Nasdaq: ENLV)"){kind=logo}
Enlivex Therapeutics (Nasdaq: ENLV)
Immune rebalancing
Israel
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
Aurora, United States
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
Waltham, United States
Xenikos B.V.
Developing new, innovative immunotherapy medicines that reset the immune system
Nijmegen, The Netherlands
Track all ActiTrexx GmbH competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
San Diego, United States
Delinia
Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus o...
San Francisco, United Sta...
Sentien Biotechnologies, Inc.
Restoring Balance to the Immune System
OSE Immunotherapeutics
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Nantes, France
Angiocrine Bioscience, Inc.
Transforming medicine through engineered cellular therapies that restore, regenerate, and...
San Diego, United States
Egle Therapeutics
Modulating T-regulatory cells to balance immunity
Paris, France
SQZ Biotechnologies
Unlocking the full potential of cell therapies for patients around the world
Watertown, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
About ActiTrexx GmbH
ActiTrexx GmbH is a biotech startup founded in 2020, with a vision to provide a curative cellular therapy to prevent inflammatory reactions in conditions such as GvHD, solid organ transplantation, and autoimmune diseases. The company's flagship product, ATreg, leverages regulatory T cells (Treg) to offer a safe and eff...
Biotech Startup, Cellular Therapy, Regulatory T Cells, Immune System, Inflammatory Reactions, GVHD, Solid Organ Transplantation, Autoimmune Diseases, Cell-based Drug Product, ATreg, Clinical Application, Pharmaceutical Development, Mainz, Germany, Regenerative Medicine, Immunotherapy
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ActiTrexx GmbH and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ActiTrexx GmbH on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
